Trexquant Investment LP

Position in CYTK — Cytokinetics Inc

CIK 1633445 STAMFORD, CT

Position in CYTK

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$9,808,265

+$6,632,063 QoQ

Shares Held

115,134

+138.9% QoQ

Ownership

0.083%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#124

of 477 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 91% Shared 0% None 9%

Healthcare · as of Jun 30, 2026

Trexquant Investment LP holds $587,455,425 across 144 Biotechnology names. CYTK ranks #14 (1.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRNA	Moderna, Inc.	505,160	$35,376,354
2	REGN	Regeneron Pharmaceuticals, Inc.	41,839	$26,088,290
3	RVMD	Revolution Medicines, Inc.	120,122	$22,496,448
4	AXSM	Axsome Therapeutics, Inc.	83,679	$20,482,108
5	RARE	Ultragenyx Pharmaceutical Inc.	556,385	$18,577,695
6	INSM	INSMED Inc	156,553	$16,691,680
7	SRRK	Scholar Rock Holding Corp	275,712	$15,164,160
8	EXEL	Exelixis, Inc.	275,209	$14,974,121

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$9,808,265	115,134	+138.9%	Shares	Sole	2026-08-14
2026-03-31	$3,176,202	48,190	+342.4%	Shares	Sole	2026-05-15
2025-06-30	$359,937	10,894	-61.8%	Shares	Sole	2025-08-12
2024-06-30	$1,544,563	28,508	-73.1%	Shares	Sole	2024-08-13
2024-03-31	$7,441,405	106,139	-3.3%	Shares	Sole	2024-05-14
2023-12-31	$9,168,036	109,810	+411.5%	Shares	Sole	2024-02-09
2023-09-30	$632,447	21,468	+11.4%	Shares	Sole	2023-11-13
2021-06-30	$381,274	19,266	-38.0%	Shares	Sole	2021-08-12
2020-09-30	$673,141	31,092	-25.7%	Shares	Sole	2020-11-06
2020-06-30	$986,946	41,873	-36.7%	Shares	Sole	2020-08-07
2020-03-31	$779,613	66,125	—	Shares	Sole	2020-05-08
No filing history on record for this holder in this stock.